Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Causes of hyperprolactinaemia in the primary care setting: How to optimise hyperprolactinaemia management
Ana M. García Cano; Lucía Jiménez Mendiguchía; Marta Rosillo Coronado; Ana Gómez Lozano; Ángel Luis del Rey-Mejías; María Fresco Merino; Marta Marchán Pinedo; Marta Araujo-Castro;
Endocrinol Diabetes Nutr. 2022;69:771-8
Thyroid disorders associated with immune control point inhibitors
Enzamaria Fidilio; Elena Navarro-González; Ana R. Romero-Lluch; Pedro Iglesias; Juan José Diez Gómez; Emma Anda Apiñániz; Estefanía Santos Mazo; Carles Zafón;
Endocrinol Diabetes Nutr. 2021;68:408-15
Sexual function and depressive symptoms in men with hypoprolactinaemia secondary to overtreatment of prolactin excess: A pilot study
Robert Krysiak; Karolina Kowalcze; Bogus¿aw Okopie¿;
Endocrinol Diabetes Nutr. 2022;69:279-88